HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

NCT05586074 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Acute Myeloid (AML)

Interventions

DRUG: Clifutinib
DRUG: LoDAC
DRUG: Azacitidine
DRUG: Decitabine
DRUG: Ara-C±IDA
DRUG: FLAG-IDA

Sponsor

Sunshine Lake Pharma Co., Ltd.